The Work and Social Adjustment Scale (WSAS; Mundt et al., 2002) is a five-item adult self-report measure of functional impairment across key areas of daily life attributable to a person’s difficulties.
Each WSAS item rates the degree of impairment in a specific life domain (work, home management, social leisure, private leisure, or close relationships) on a nine-point scale, ranging from 0 (not at all impaired) to 8 (very severely impaired).
Item 1 (work) includes an additional response option: “I am not working for reasons unrelated to my difficulties.” This accommodates respondents who are not currently in paid work (e.g., retired individuals, students, or full-time caregivers) where rating impairment in “ability to work” does not apply meaningfully. When selected, item 1 is scored as 0, and the total is calculated normally.
The WSAS total score is calculated as the sum of the five item ratings and ranges from 0 to 40, with higher scores indicating greater overall functional impairment. Both the total score and item-level responses are clinically informative: the total provides an overall index of functional impairment, while item-level responses identify which specific life domains are affected.
The following descriptors are applied to the WSAS total score, based on the original severity bands proposed by Mundt et al. (2002):
To provide additional interpretive context, percentile rankings are derived from a reference sample of adults at intake for primary-care psychological therapy (Zahra et al., 2014). These percentiles indicate a respondent’s position relative to others entering outpatient therapy, not relative to the general population. For example, a total score of 10 corresponds to approximately the 17th percentile in this reference sample, indicating that roughly one in six adults entering primary-care therapy scored at or below this level. A score of 19 corresponds to approximately the 50th percentile (close to the reference sample average), and a score of 30 corresponds to approximately the 89th percentile.
When WSAS scores are available from multiple timepoints, changes in scores can provide valuable information about the effectiveness of interventions or changes in functional impairment. Changes of at least 0.5 standard deviations are considered clinically meaningful (Norman et al., 2003; Turner et al., 2010). Based on Zahra et al. (2014), the minimally important difference (MID) = 5 points. These changes are categorised as:
Of note, Zahra et al. (2014) proposed an 8-point change as clinically meaningful, derived from the measurement error of the WSAS. NovoPsych instead uses a 5-point change, consistent with what patients typically perceive as a meaningful change in functioning.
On first administration, the report displays a summary table with the WSAS total score and severity descriptor, accompanied by a bar graph showing the total score against the severity descriptor bands. An item-level graph shows the respondent’s response to each of the five WSAS items, supporting treatment-target conversations by making the relative impairment across life domains visible.


On repeat administrations, a multi-administration line chart plots the total score over time, with severity band shading to show the trajectory of overall functional impairment. The item-level graph is separated by item to show how each domain’s response has changed across administrations.

The WSAS was developed by Mundt et al. (2002) as a brief, self-report measure of patient-rated functional impairment. The original validation drew on data from 382 adults with depression and 197 adults with obsessive-compulsive disorder (OCD). Subsequent validation studies have extended this evidence base across multiple clinical populations and translated language versions (e.g., Lundqvist et al., 2024; Heissel et al., 2021; Shih et al., 2021; Tolchard, 2016).
Mundt et al. (2002) originally framed each item with the placeholder “Because of my [disorder]…”, suggesting that substitutions be implemented to suit clinical needs. Subsequent validation studies have used substitutions such as “my condition” (Zahra et al., 2014) and “the way I feel” (Thandi et al., 2017). The NovoPsych implementation uses “my difficulties,” chosen to keep the measure applicable across the widest range of clinical presentations and to reflect that people often face multiple co-occurring difficulties.
The WSAS is unidimensional and scored as a single total. Multiple large samples (Pedersen et al., 2017; Heissel et al., 2021; Lundqvist et al., 2024) have confirmed this one-factor structure through confirmatory factor analysis. Items 3 (social leisure) and 5 (close relationships) show some overlap because both assess social aspects of functioning. However, this overlap is small and does not warrant treating them as a separate subscale.
Internal consistency for the WSAS total score is strong and well-replicated. Mundt et al. (2002) reported Cronbach’s α ranging from .70 to .94 across multiple administrations in the development samples. Zahra et al. (2014) replicated this in the largest WSAS study to date (α = .82, N = 4,835 adults receiving routine UK primary-care psychological therapy primarily for anxiety or depression), and Lundqvist et al. (2024) reported α = .82 in 1,157 Norwegian community mental health patients.
Test-retest reliability evidence is limited but supportive. Mundt et al. (2002) reported r = .73 over two weeks in the OCD sample, Jansson-Fröjmark (2014) reported r = .99 over a one-week interval in 41 patients with chronic insomnia, and Vázquez Morejón et al. (2021) reported r = .78 over a two-to-three-week interval in a Spanish outpatient sample. No test-retest data have been reported for the largest UK primary care or psychiatric outpatient samples.
Convergent validity. WSAS scores correlate strongly with symptom severity. Mundt et al. (2002) reported strong correlations with the Hamilton Rating Scale for Depression (HRSD; r = .76) and the Yale-Brown Obsessive Compulsive Scale (Y-BOCS; r = .61). Zahra et al. (2014) extended these findings in 4,835 adults receiving routine UK primary-care psychological therapy primarily for anxiety or depression, reporting correlations between WSAS scores and PHQ-9 (r = .58 to .74) and GAD-7 (r = .43 to .68) at intake and discharge.
Discriminant validity. Despite these correlations with symptom measures, the WSAS captures a distinct construct. Principal component analysis in the same UK primary-care sample (Zahra et al., 2014) showed that the WSAS loads on a factor separate from depression and anxiety symptoms, supporting its status as a measure of functional impairment rather than a proxy for symptom severity.
The WSAS is responsive to treatment-related change. Significant pre-post WSAS reductions have been demonstrated across diverse clinical populations and treatment contexts: depression and OCD (Mundt et al., 2002), phobic disorders (Mataix-Cols et al., 2005), routine UK primary-care psychological therapy (Zahra et al., 2014), Norwegian psychiatric outpatient treatment (Pedersen et al., 2017), and chronic insomnia (Jansson-Fröjmark, 2014). Effect sizes have ranged from moderate to large across these contexts. Jansson-Fröjmark (2014) further showed significant reductions only in the active treatment groups, not in the wait-list controls, supporting the conclusion that the observed WSAS changes reflect treatment effects rather than spontaneous improvement.
The reference sample used for percentile calculation on NovoPsych is the UK primary care baseline sample (Zahra et al., 2014; N = 4,835; mean 18.81, SD 9.17), the largest WSAS sample with reported distributional details. Other large clinical samples provide useful context for interpreting scores in specific populations: Lundqvist et al. (2024) reported diagnosis-specific averages (in a Norwegian psychiatric outpatient subsample of 1,051 with a single main diagnosis) ranging from 19.2 (primary ADHD) to 24.3 (primary depression), and Pedersen et al. (2017; N = 1,371 Norwegian outpatients in personality-disorder-focused treatment programs) reported averages of 23.9 for outpatients with personality disorders and 20.1 for those without.
No known general-population (non-help-seeking) WSAS reference sample has been published. The percentiles displayed in NovoPsych describe a respondent’s position relative to adults entering primary-care psychological therapy, not the general population.
Two descriptive severity band systems have been proposed in the WSAS literature.
NovoPsych applies the Mundt bands as the primary interpretive framework, reflecting their widespread clinical use and their role in the broader WSAS research literature. The Mataix-Cols bands have stronger external-validation evidence in Pedersen et al.’s (2017) head-to-head comparison: the Mundt bands fail to differentiate subclinical from significant-impairment groups on the Global Assessment of Functioning. A further limitation is that the Mundt top band captures the majority of routine clinical samples (53.6% of psychiatric outpatients in Lundqvist et al., 2024), indicating limited discrimination at the upper end.
The WSAS is designed for adults (aged 18 and over) experiencing functional impairment typically due to a mental or physical health difficulty. It is transdiagnostic and has been validated across diverse clinical populations, including depression, OCD, phobic disorders, chronic insomnia, problem gambling, primary-care psychological therapy, and psychiatric outpatient settings.
Because the WSAS does not anchor responses to a specific diagnosis/disorder, it can be used wherever functional impact is a relevant clinical consideration — including with clients whose presentation does not fit neatly into one diagnostic category, or whose difficulties involve co-occurring mental and physical health conditions. The WSAS has not been validated in children or adolescents and is not recommended for respondents under 18.
Yes. The WSAS is brief, transdiagnostic, and sensitive to treatment-related change across diverse clinical populations and treatment contexts. A change of 5 or more points in the total score is considered clinically meaningful, reflecting a 0.5 standard deviation shift relative to the UK primary care reference sample.
On repeat administration, the NovoPsych report displays a multi-administration line chart of the total score with severity-band shading, item-level charts showing change in each life domain, and a narrative summary of the change from baseline. Because items are anchored to “my difficulties,” it is important to remind clients to rate against the same identified difficulties at each administration to ensure scores remain comparable over time.
The wording was chosen deliberately to keep the WSAS broadly applicable. The original items used a placeholder format (“because of my [disorder]…”), and subsequent validation studies have substituted alternatives such as “my condition” or “the way I feel” to suit different clinical contexts. The NovoPsych version uses “my difficulties” to accommodate clients who may have a single concern, multiple co-occurring problems, or no formal diagnosis at all. In practice, it can be helpful to briefly orient the client before the first administration: ask them to hold in mind the difficulties they have come to therapy to address, and to rate impairment specifically attributable to those difficulties rather than the impact of unrelated life circumstances.
For repeated-measures use, encourage clients to use the same anchor each time they complete the WSAS as shifting the anchor mid-treatment would change the meaning of any observed score change and limit progress comparisons.
captures a distinct construct from symptom severity, and research has shown that WSAS scores load on a factor separate from depression and anxiety symptoms even when correlations between them are moderate to strong. A discrepancy can indicate several things.
These mismatches are particularly useful at treatment review: symptom reduction without functional gain is a common signal to revisit the case formulation and consider whether the most clinically meaningful treatment targets have been identified.
No. The WSAS quantifies the real-world impact of a person’s difficulties on daily functioning but does not identify or confirm any specific diagnosis. That said, it speaks directly to a criterion that runs through much of the DSM-5-TR: most disorders require evidence that symptoms cause “clinically significant distress or impairment in social, occupational, or other important areas of functioning” before the diagnostic threshold is met. The five WSAS domains map closely onto this criterion, making the measure a useful adjunct to symptom-focused tools when establishing whether the impairment threshold has been reached. Used alongside diagnosis-specific measures (such as the SADS, PSWQ, CESD-R, or PCL-5), the WSAS adds the functional dimension that those measures do not capture and supports a more complete clinical picture for diagnostic and treatment-planning decisions.
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. H. (2002). The Work and Social Adjustment Scale: A simple measure of impairment in functioning. British Journal of Psychiatry, 180(5), 461–464. https://doi.org/10.1192/bjp.180.5.461
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
Heissel, A., Bollmann, J., Kangas, M., Abdulla, K., Rapp, M., & Sanchez, A. (2021). Validation of the German version of the Work and Social Adjustment Scale in a sample of depressed patients. BMC Health Services Research, 21, 593. https://doi.org/10.1186/s12913-021-06622-x
Jansson-Fröjmark, M. (2014). The Work and Social Adjustment Scale as a measure of dysfunction in chronic insomnia: Reliability and validity. Behavioural and Cognitive Psychotherapy, 42(2), 186–198. https://doi.org/10.1017/S135246581200104X
Lundqvist, L.-O., et al. (2024). The Work and Social Adjustment Scale (WSAS): An investigation of reliability, validity, and associations with clinical characteristics in psychiatric outpatients. PLOS ONE, 19(10), e0311420. https://doi.org/10.1371/journal.pone.0311420
Mataix-Cols, D., Cowley, A. J., Hankins, M., Schneider, A., Bachofen, M., Kenwright, M., Gega, L., Cameron, R., & Marks, I. M. (2005). Reliability and validity of the Work and Social Adjustment Scale in phobic disorders. Comprehensive Psychiatry, 46(3), 223–228. https://doi.org/10.1016/j.comppsych.2004.08.007
Mundt, J. C., Marks, I. M., Shear, M. K., & Greist, J. H. (2002). The Work and Social Adjustment Scale: A simple measure of impairment in functioning. British Journal of Psychiatry, 180(5), 461–464. https://doi.org/10.1192/bjp.180.5.461
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592. https://doi.org/10.1097/01.MLR.0000062554.74615.4C
Pedersen, G., Kvarstein, E. H., & Wilberg, T. (2017). The Work and Social Adjustment Scale: Psychometric properties and validity among males and females, and outpatients with and without personality disorders. Personality and Mental Health, 11(4), 215–228. https://doi.org/10.1002/pmh.1382
Shih, C.-Y., Zhang, Y., Lai, C. Y. Y., Leung, C., Bressington, D., & Molassiotis, A. (2021). Psychometric properties of Chinese version of Work and Social Adjustment Scale for outpatients with common mental disorders: Classical test theory and Rasch analysis. East Asian Archives of Psychiatry, 31(4), 97–104. https://doi.org/10.12809/eaap20101
Thandi, G., Fear, N. T., & Chalder, T. (2017). A comparison of the Work and Social Adjustment Scale (WSAS) across different patient populations using Rasch analysis and exploratory factor analysis. Journal of Psychosomatic Research, 92, 45–48. https://doi.org/10.1016/j.jpsychores.2016.11.009
Tolchard, B. (2016). Reliability and validity of the Work and Social Adjustment Scale in treatment-seeking problem gamblers. Journal of Addictions Nursing, 27(4), 229–233.
Turner, D., Schünemann, H. J., Griffith, L. E., Beaton, D. E., Griffiths, A. M., Critch, J. N., & Guyatt, G. H. (2010). The minimal detectable change cannot reliably replace the minimal important difference. Journal of Clinical Epidemiology, 63(1), 28–36. https://doi.org/10.1016/j.jclinepi.2009.01.024
Vázquez Morejón, A. J., Vázquez-Morejón, R., & Conde Álvarez, P. (2021). Work and Social Adjustment Scale (WSAS): Psychometric characteristics of a Spanish adaptation in a clinical population. Behavioural and Cognitive Psychotherapy, 49(6), 764–768. https://doi.org/10.1017/S1352465821000308
Zahra, D., Qureshi, A., Henley, W., Taylor, R., Quinn, C., Pooler, J., Hardy, G., Newbold, A., & Byng, R. (2014). The Work and Social Adjustment Scale: Reliability, sensitivity and value. International Journal of Psychiatry in Clinical Practice, 18(2), 131–138. https://doi.org/10.3109/13651501.2014.894072